Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-BCT-1: Carboplatin and Paclitaxel in Breast Cancer
NCT02546232Phase 2Active, not recruiting
- Sponsor
- Oslo University Hospital
- Start
- Apr 2015
- Primary completion
- Dec 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin in breast cancer, sponsored by Oslo University Hospital. Started Apr 2015; status: active, not recruiting.
02
Drugs
carboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02546232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02546232.